Kasper Mygind

Kasper’s scientific journey started deep inside the cell — tracing how proteins navigate from the endoplasmic reticulum through the Golgi apparatus, and the molecular switches that keep this system in order. That foundation shaped his approach to genome engineering, where he has built a library of CRISPR-based reporter cell lines to study protein function and cell-cell interactions in vitro and in vivo. Today, his focus has shifted to RNA biology and therapy: understanding how RNA-level regulation shapes cancer behaviour, and how that knowledge can be turned into new therapeutic strategies.

Alongside his science, Kasper has a genuine passion for innovation and entrepreneurship. He thinks not just about the next experiment, but about where discoveries could go beyond the lab.